Advancing A Proposed Strategic Merger, Nasdaq Profile (ALBT) Tops Monday's Watchlist

See this past Friday's breakout idea?

*Sponsored Advancing A Proposed Strategic Merger, Nasdaq Profile (ALBT) Tops Monday's Watchlist July 27th Greetings, Friend! See this past Friday's breakout idea? Swinging from a low of $1.10, it rocketed to a two-week high of $1.45. That move resulted in a surge of approx. 31% intraday! Not shabby, but here's this... A recently proposed merger could start propelling a biotech innovator into new frontiers of AI-driven business automation, combining cutting-edge medical science with advanced technology solutions. This union could enhance operational efficiencies while accelerating growth in both heal.thcare and AI sectors. Positioned at the intersection of these rapidly evolving industries, this collaboration signals transformative potential at the ground floor. And with a low float of fewer than 2Mn shares, game-changing news in the recent term, and this proposed merger stirring buzz, there should be little confusion as to why this Nasdaq breakout idea is on my radar: Avalon GloboCare Corp. (Nasdaq: ALBT) Avalon GloboCare Corp. is a developer of precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. Avalon is currently marketing the KetoAir™ breathalyzer device, which is owned and manufactured by Qi Diagnostics Limited, and plans to develop additional diagnostic uses of the breathalyzer technology. Delivering Precision Diagnostics and Laboratory Services Avalon achieves and fosters seamless integration of unique verticals to bridge and accelerate innovative research, bio-process development, clinical programs and product commercialization. Research and Development Avalon is focused on bringing forward intellectual property through joint patent filings with the Massachusetts Institute of Technology (MIT), led by Professor Shuguang Zhang as Principal Investigator.  Using the unique QTY code protein design platform, six water-soluble variant cytokine receptors have been successfully designed and tested to show binding affinity to the respective cytokines. The company is currently focused on bringing forward the intellectual property associated with this program through joint patent submissions. KetoAir™ Breathalyzer Avalon is exploring the commercialization and development of a versatile breathalyzer system. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units (ppm, part-per-million) such that the user will know his/her real-time ketosis status: inadequate ketosis (0-3.99 ppm), mild ketosis (4-9.99 ppm), optimal ketosis (10-40 ppm), or alarming level (> 40 ppm). The breathalyzer is registered with the United States FDA as a Class I medical device (US FDA registration # 3026284320). Grab Sources Here: ALBT Website. ----- These 5 Potential Catalysts Could Lend (Nasdaq: ALBT) A Breakout Spark #1. Avalon GloboCare Advances Major Strategic Merger With YOOV Group. Avalon GloboCare’s proposed merger with YOOV marks a major strategic shift to artificial intelligence-as-a-service, aiming to deliver intelligent business automation solutions. The combined entity will help organizations optimize operations, reduce costs, and improve service delivery through advanced AI technology, building on YOOV’s strong recent revenue and growth. #2. ALBT Has A Very Low Float (Volatility Potential May Be Explosive). Sporting a float of roughly 1.45Mn shares, according to Yahoo Finance, volatility potential could pop up in a flash. #3. Avalon GloboCare Secures Strategic 20-Year Patent Protection In Hong Kong for Advanced CAR-T And CAR-NK Cell Technology. Avalon GloboCare achieved a major milestone with a 20-year patent issued in Hong Kong safeguarding its innovative CAR-T and CAR-Natural Killer (NK) cell technology. Co-developed with Arbele Limited, this technology features a bispecific Anti-CD19xCD22 CAR design to reduce tumor escape and localized cytokine induction to boost immune response, enhancing therapeutic efficacy. This strengthens Avalon's global position in pioneering cell-based immunotherapy and intellectual property protection through 2040. #4. Avalon GloboCare Partners With Qi Diagnostics To Develop Real-Time Cann-a-bis Breathalyzer. Avalon GloboCare’s collaboration with Qi Diagnostics aims to co-develop a VOC nanosensor-based cann-a-bis breathalyzer for real-time detection of potential impaired driving. This innovative, non-invasive diagnostic device supports public safety by enabling quick cann-a-bis impairment screening. Leveraging Avalon’s regulatory expertise and Qi Diagnostics’ nanosensor technology, the partnership advances Avalon’s commitment to delivering impactful precision diagnostic solutions enhancing law enforcement and workplace safety. #5. Avalon GloboCare Partners With Pounds Transformation Clinics To Launch Innovative KetoAir BrAce 4 Impact Challenge. Avalon GloboCare’s partnership with Pounds Transformation Clinics introduces the KetoAir™ breathalyzer to support ketogenic hea.lth management in weight loss programs.  The device offers real-time ketone monitoring, motivating patients to stay on track and achieve better results. Available at three Connecticut clinics, the collaboration enhances personalized wellness journeys through innovative, accessible technology, promoting sustained lifestyle changes and improved hea.lth outcomes. ----- It's official. Coverage is underway on Avalon GloboCare Corp. (Nasdaq: ALBT). Be on the lookout for updates coming soon. All the best, Dane James Editor Market Pulse Today (Remember: St-ock Prices Could Be Significantly Lower Now From The Original Dates I Provided.) *MarketPulseToday.com (“MarketPulseToday” or “MPT” ) is owned by Thousand Sun Media LLC, MPT is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile MPT brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors. Avalon GloboCare Corp. (ALBT:US) previously changed their symbol from Avalon GloboCare Corp. (AVCO:US) Pursuant to an agreement between Thousand Sun Media LLC and TD Media LLC, Thousand Sun Media LLC has been hired for a period beginning on 07/27/2025 and ending on 07/28/2025 to publicly disseminate information about (ALBT:US) via digital communications. Under this agreement, Thousand Sun Media LLC has been paid six thousand five hundred USD ("Funds"). These Funds were part of the funds that TD Media LLC received from a third party who did not receive the Funds directly or indirectly from the Issuer and does not own st-ock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither Thousand Sun Media LLC, TD Media LLC and their member own shares of (ALBT:US). Please see important disclosure information here: https://marketpulsetoday.com/disclosure/albt-lz4uo/#details

Market Pulse Today | 1314 E LAS OLAS BLVD UNIT #2170 | FORT LAUDERDALE, FL 33301 US Unsubscribe | Update Profile | Our Privacy Policy | Constant Contact Data Notice